Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Steven Treon, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the current research priorites in Waldenström’s Macroglobulinemia (WM) at the Bing Center. Dr Treon was speaking at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.